Skip to main content
Jennison Associates logoJennison Associates logo
  • About Us
  • Equity

    • Large Cap Growth
    • Global
    • International
    • Emerging Markets
    • Mid Cap Growth
    • Small Cap Core

    Equity

    • SMid Cap Core
    • Large Cap Value
    • Global Equity Income
    • Rising Dividend

    Thematic Equity

    • Health Sciences
    • Utility Equity
    • Global Infrastructure
    • Global Natural Resources
    • MLP (Master Limited Partnerships)
    • Financial Services

    Thematic Equity

    • Technology Equity
  • Fixed Income
    • Active Long Duration
    • Active Core
    • Active Intermediate
    • Stable Value
    • LDI
  • ESG Overview
    • Integration
    • Proxy Voting
    • Engagement
    • Corporate Citizenship
  • Perspectives
  • Contact Us
jennison swoosh_1290x842.jpg
Equity

A True Alternative: Long/Short Allocations to Health CareATrueAlternative:Long/ShortAllocationstoHealthCare

By Daniel Matviyenko — Apr 1, 2022

8 mins

Share
  • Mail
  • LinkedIn
  • Twitter
  • Copy URL

Share

  • We believe health care is an extraordinary opportunity for alternative investment managers. The global health care sector is large, complex, and, in our view, well positioned in today’s economic and market environment.
  • Skilled managers with experience and resources have a range of options to exploit the sector’s inefficiencies and potentially profit from its innovations.
  • Despite increased risks, a long/short equity allocation to health care can provide significant portfolio benefits, including alpha potential, diversification, and exposure to long-term growth trends. More than 10,000 Americans on average qualify for Medicare1 every day, and the “graying of the population” is a global trend.

Health care is one of the largest (see Exhibit) and most diverse sectors in the global markets. It includes vast conglomerates of hospitals and caregivers, biotech start-ups, medical device manufacturers, life sciences tools, and networks of pharmaceutical companies. The sector’s public companies are fiercely competitive and profit-driven, but health care is also a vital service. Its customer base includes most of the population, and its position in the global economy is driving rapid scientific and technological advancements.

The convergence of technology and consumerization is fueling an unprecedented flow of innovation to address unmet medical needs and reduce costs. The sector is already being transformed by millennials, who are unlikely to put up with the bureaucracy, inflexibility, and one-size-fits-all approach that characterized health care interactions before the pandemic. At the same time, we expect technological developments — in everything from record keeping, to wearable sensors, to gene-based treatments — will force companies to adapt.

The acceleration of innovation in the sector will have a lasting impact on the patient experience as the industry switches to more preventive medicine and an outcome-based economic model. This backdrop presents unique opportunities for skilled active managers to generate alpha opportunities — both long and short — across multiple health-care industries:

  • Biopharmaceutical companies now have a number of different ways to treat diseases, and the types of technologies being employed are increasing at a rapid rate. As more therapies come to the public market, an investor must consider not only which therapies will be most successful in shaping patient outcomes, but also which will be approved by regulators, reimbursed by insurers, and adopted by physicians and patients. Many tenured managers in the industry have analyzed clinical trials and drug launches over different economic cycles, which helps with pattern recognition to identify which companies may be most (and least) successful, creating significant potential for alpha generation.
  • Medical device companies can improve or simplify the surgical process by making it less invasive or more automated. Analysts can assess which devices have more technological advantages and greater adoption by medical professionals. Short opportunities can arise when these companies leverage technologies that will become obsolete or where market expansion or reimbursement will be more difficult than expected. 
  • Medical tools and diagnostics companies have developed technologies that take the guesswork out of care and make it easier and more convenient for patients to be engaged in their health. These tools can accelerate the research and manufacturing process to further interrogate biologic systems and their interactions. An active long/short approach can capitalize on the technological dynamic by investing in companies with long-term growth potential while shorting those companies that lack exposure to improved technologies when new innovations begin to take share. 
  • Health care service companies are implementing technologies that can lower the cost of care and improve outcomes, such as initiatives that keep patients out of hospitals or efforts that shift procedures to lower-cost sites of care. By investing in companies that stand to benefit from a move from fee-for-service to fee-for-value models and shorting those companies that fail to reduce cost profiles or improve access to care for patients, an active manager can generate returns on both sides of the portfolio. Selecting the right investments is essential, as this approach can significantly increase the risk of loss.

The sector’s long-term — and short-term — prospects should also be considered. Many investors are aware that health care has solid long-term fundamentals; more than 10,000 Americans qualify for Medicare every day, and the “graying” of the population is a global trend.

However, we also see opportunities in global health care because of once-in-a-generation conditions in the current environment that are making the sector one of the fastest growing areas of the global market.2 Health care services and procedures have been severely curtailed by the COVID-19 pandemic, which has drawn the focus of the industry, prevented one-on-one interactions, and hobbled the agencies responsible for conducting inspections and reviewing drug approvals. As societies and economies around the world reopen, we believe health care will be one of the primary beneficiaries.

Demand for health care services will likely accelerate as patients return to medical offices, more procedures are scheduled, and medical facilities open. While the sector does face challenges — COVID-19 variations remain a threat, a new commissioner was only recently appointed to the FDA, and the political landscape can change over time — the earnings potential should remain high.

The health care sector can also offer the opportunity to generate alpha with low correlations to other sectors as well as to other alternative investment strategies. It’s notable that some areas of health care have been out of market favor for long periods, raising its diversification potential even higher, in our view.

Finally, an alternative investment in health care offers investors potential exposure to true active management skill in a sector that requires both medical and financial expertise, especially in a market where many active managers (and their results) can be scarcely distinguished from their passive counterparts. Long and short positioning gives managers the potential to fully leverage their insights, perspective, and experience on behalf of clients.

Contact Us
Jennison Associates

Jennison's investing approach is rooted in our fundamental research and security selection; all of our portfolios are built from the bottom-up, security by security.

Contact Us

  • By Daniel MatviyenkoManaging Director, Jennison Associates

1“By 2030, All Baby Boomers Will Be Age 65 or Older,” US Census Bureau, December 10, 2019.

2ResearchAndMarkets.com: Healthcare Global Market Opportunities And Strategies To 2022

 

IMPORTANT INFORMATION

Investing in the health care sector increases vulnerability to economic, political, or regulatory developments affecting this sector. The share price of a health care company can drop dramatically. A short sale creates the risk of a theoretically unlimited loss.

This material is only intended for investors which meet qualifications as institutional investors as defined in the applicable jurisdiction where this material is received. This material is not for use by retail investors and may not be reproduced or distributed without Jennison Associates LLC's permission. These materials are for informational or educational purposes only. The information is not intended as investment advice and is not a recommendation about managing or investing assets.

Jennison makes no representations regarding the suitability of any securities, financial instruments or strategies described in these materials. In providing these materials, Jennison is not acting as your fiduciary. These materials do not purport to provide any legal, tax or accounting advice. Jennison Associates LLC (`Jennison') has not been licensed or registered to provide investment services in any jurisdiction outside the United States.

The information contained in this document should not be construed as a solicitation or offering of investment services by Jennison or a solicitation to sell or a solicitation of an offer to buy any shares of any securities (nor shall any such securities be offered or sold to any person) in any jurisdiction where such solicitation or offering would be unlawful under the applicable laws of such jurisdiction. Please visit https://www.jennison.com/important-disclosures for important information, including information on non-US jurisdictions.

The views expressed herein are those of Jennison investment professionals at the time the comments were made and may not be reflective of their current opinions and are subject to change without notice and should not be considered investment advice.

Certain third party information in this document has been obtained from sources that Jennison believes to be reliable as of the date presented; however, Jennison cannot guarantee the accuracy of such information, assure its completeness, or warrant such information will not be changed. Jennison has no obligation to update any or all such third party information. There is no assurance that any forecasts, targets, or estimates will be attained.

The financial indexes referenced herein are provided for informational purposes only. All indexes referenced are registered trade names or trademark/ service marks of third parties. References to such trade names or trademark/service marks and data are proprietary and confidential and cannot be redistributed without Jennison's prior consent. Investors cannot directly invest in an index.

The Global Industry Classification Standard (GICS®) is the exclusive intellectual property of MSCI Inc. (MSCI) and Standard & Poor’s Financial Services, LLC (S&P). Neither MSCI, S&P, their affiliates, nor any of their third party providers (“GICS Parties”) makes any representations or warranties, express or implied, with respect to GICS or the results to be obtained by the use thereof, and expressly disclaim all warranties, including warranties of accuracy, completeness, merchantability and fitness for a particular purpose. The GICS Parties shall not have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) even if notified of such damages.

MSCI World Index: The MSCI World Index is a broad global equity index that represents large and mid-cap equity performance across all 23 developed markets countries. It covers approximately 85% of the free float-adjusted market capitalization in each country.

MSCI information may only be used for your internal use, may not be reproduced or redisseminated in any form and may not be used as a basis for or a component of any financial instruments or products or indices. None of the MSCI information is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such. Historical data and analysis should not be taken as an indication or guarantee of any future performance analysis, forecast or prediction. The MSCI information is provided on an “as is” basis and the user of this information assumes the entire risk of any use made of this information. MSCI, each of its affiliates and each other person involved in or related to compiling, computing or creating any MSCI information (collectively, the “MSCI Parties”) expressly disclaims all warranties (including, without limitation, any warranties of originality, accuracy, completeness, timeliness, non-infringement, merchantability and fitness for a particular purpose) with respect to this information. Without limiting any of the foregoing, in no event shall any MSCI Party have any liability for any direct, indirect, special, incidental, punitive, consequential (including, without limitation, lost profits) or any other damages.

  • About Us

    • About Jennison
    • Firm Profile
    • Our Approach to Investing
    • Contact Us - Form
  • Other Resources

    • Form CRS
Jennison Associates logo
  • Terms & Conditions
  • PGIM Privacy Center
  • Accessibility Help
  • Cookie Preference Center

Jennison Associates LLC. All Rights Reserved.

This website is intended for Institutional and Professional Investors only. All investments involve risk, including the possible loss of capital.

Important Disclosures

Jennison Associates is a registered investment advisor and a Prudential Financial company. Jennison Associates LLC has not been licensed or registered to provide investment services in any jurisdiction outside the United States. Certain investment vehicles are distributed or offered through Prudential Investment Management Services LLC (also a Prudential Financial Company) or other affiliated entities. Additionally, vehicles may not be registered or available for investment in all jurisdictions.

Please click on this disclosure link for important information, including information on non-US jurisdictions.

This web site is not intended as an offer or solicitation with respect to the purchase or sale of any security or other financial instrument or any investment management services. It does not constitute investment advice, should not be used as the basis for any investment decision, and does not purport to provide any legal, tax or accounting advice. This is for informational and educational purposes only and should not be construed as investment advice or an offer or solicitation in respect of any products or services to any persons who are prohibited from receiving such information under the laws applicable to their place of citizenship, domicile or residence.

Any views or opinions expressed on this website reflect the opinions of Jennison investment professionals at the time they are made and are subject to change.

Your investment objectives, risk tolerance, and liquidity needs must be reviewed before suitable programs can be recommended. Asset allocation and diversification strategies do not assure a profit or protect against loss in declining markets. Investors should consult with their attorney, accountant, and/or tax professional for advice concerning their particular situation.

Please remember that there are inherent risks involved with investing in the markets, and your investments may be worth more or less than your initial investment upon redemption. There is no guarantee that the investment managers’ objectives will be achieved. Further, there is no assurance that any strategies, methods, sectors, or any investment programs herein were or will prove to be profitable, or that any investment recommendations or decisions we make in the future will be profitable for any investor or client. Professional money management is not suitable for all investors.

There is no guarantee our objectives will be met. All investments contain risk, including possible loss of principal. The strategy may vary significantly from the benchmark in several ways including, but not limited to, sector and issuer weightings, portfolio characteristics, and security types.

Information for persons in the United Kingdom and various European Economic Area jurisdictions
In the United Kingdom, information is issued by PGIM Limited with registered office: Grand Buildings, 1-3 Strand, Trafalgar Square, London, WC2N 5HR. PGIM Limited is authorised and regulated by the Financial Conduct Authority (“FCA”) of the United Kingdom (Firm Reference Number 193418). In the European Economic Area (“EEA”), information is issued by PGIM Netherlands B.V. with registered office: Gustav Mahlerlaan 1212, 1081 LA  Amsterdam, The Netherlands. PGIM Netherlands B.V. is authorised by the Autoriteit Financiële Markten (“AFM”) in the Netherlands (Registration number 15003620) and operating on the basis of a European passport. In certain EEA countries, information is, where permitted, presented by PGIM Limited in reliance of provisions, exemptions or licenses available to PGIM Limited under temporary permission arrangements following the exit of the United Kingdom from the European Union. Jennison Associates LLC, PGIM Limited & PGIM Netherlands B.V. are wholly owned subsidiaries of PGIM, Inc. the principal investment management business of Prudential Financial, Inc. (‘PFI’).  PFI of the United States is not affiliated in any manner with Prudential plc, incorporated in the United Kingdom or with Prudential Assurance Company, a subsidiary of M&G plc, incorporated in the United Kingdom. These materials are issued by PGIM Limited and/or PGIM Netherlands B.V. to persons who are professional clients as defined  under the rules of the FCA and/or to persons who are professional clients as defined in the relevant local implementation of Directive 2014/65/EU (MiFID II).

Links to third-party sites are intended for informational purposes only and should not be considered investment advice or recommendation to invest. These links do not constitute endorsement or confirm their accuracy, and we are not responsible for any third-party guidelines, security, or accuracy of information.

You are viewing this page in preview mode.

Edit Page